4D Molecular Therapeutics Inc. logo

4D Molecular Therapeutics Inc.

FDMT | NASDAQ
Chart Builder DCF Calculator
$16.07
+$0.83 (+5.45%)
Sep 22, 2026, 2:09 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
60.24M 149.34M 249.11M 52.35M 153M 276.73M
Short-Term Investments
342.41M 275.54M 39.12M 161.2M 94.78M n/a
Long-Term Investments
111.38M 80.58M 10.95M 4.91M 67.65M n/a
Other Long-Term Assets
9.19M 4.26M 684K 1.08M 602K 602K
Receivables
n/a n/a n/a 700K 47K 1.49M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
10.48M 10.06M 8.36M 6.26M 8.46M 4.44M
Total Current Assets
413.13M 434.93M 296.59M 220.51M 256.28M 282.66M
Property-Plant & Equipment
33.01M 40.61M 31.67M 35.35M 28.95M 5.07M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
153.58M 125.45M 43.3M 41.34M 97.21M 5.68M
Total Assets
566.71M 560.38M 339.89M 261.85M 353.49M 288.33M
Account Payables
11.16M 4.39M 3.52M 3.32M 4.76M 1.79M
Deferred Revenue
360K 257K 273K 884K 2.6M 6.59M
Short-Term Debt
n/a n/a n/a 2.66M n/a n/a
Other Current Liabilities
n/a n/a 3.87M 3.18M n/a n/a
Total Current Liabilities
43.99M 29.15M 18.95M 15.73M 16.34M 16.74M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
496K 603K 617K 233K 334K 1.97M
Total Long-Term Liabilities
17.06M 20.63M 13.11M 14.78M 18.04M 15.2M
Total Liabilities
61.05M 49.78M 32.06M 30.51M 34.38M 31.94M
Total Debt
21.41M 24.61M 14.67M 16.12M 16.45M n/a
Book Value
505.66M 510.61M 307.83M 231.34M 319.11M 256.39M
Book Value Per Share
8.73 9.47 7.87 7.15 11.51 9.61
Common Stock
6K 5K 4K 3K 3K 3K
Retained Earnings
-716.3M -576.2M -415.33M -314.49M -207M -135.68M
Comprehensive Income
727K 229K 16K -1.2M -423K -288.33M
Shareholders Equity
505.66M 510.61M 307.83M 231.34M 319.11M 256.39M
Total Investments
453.79M 356.12M 50.08M 166.11M 162.43M n/a

© 2026 bestshares.com. All rights reserved.